Brian Nowosielski

Researchers aimed to better understand the prominence of vaccine failures and breakthrough infections of pediatric pneumoccoal immunization.

From their originally intended purposes to the growing indications showing promise in development, GLP-1 and GIP receptor agonists have evolved rapidly.

Despite significant progress made in the US opioid epidemic, systemic change is necessary to move pain management forward across health care.

Empathy amongst patients’ most trusted health care providers can translate to better outcomes and health care delivery.

Following multiple exits in this role throughout President Trump’s second term, the new director’s tenure is reported to be permanent going forward.

Episode 13 assesses the evolution of MASH, how it’s managed by pharmacists, and how it provides another avenue for improving cardiometabolic disease.

In part 2 of our conversation with Duane Jones, BS Pharm, he moves from nonopioid alternatives to the new and multidisciplinary approaches toward post-operative pain protocols.

In a case study based in a community pharmacy, researchers assess the dosage regimen of an older polymedicated patient to improve adherence and pharmacotherapy.

Researchers highlight the importance of vaccination for the risk reduction needed across the pediatric population.

With its popularity increasing on TikTok, melanotan II has been given monikers like ‘vacation peptide’ and ‘Barbie drug’ because of its effect on the skin.

Duane Jones, BS Pharm, shares some of his expert knowledge into why opioids were never the right pathway for patients experiencing acute or chronic pain.

Among adult patients experiencing a transfer to skilled nursing facilities, researchers provide a detailed look into medication restart patterns following deprescribing.

Based on discussions from a recent webinar debate on the 340B Drug Pricing Program, we’re revealing how differently key stakeholders see a program that pharmacists participate in every day.

In a technologically advanced health care landscape, solutions to address language barriers are necessary and can be the difference between life and death for complex medication regimens.

As COVID-19 shifts from emergency response to routine care, persistent inequities in vaccine access are quietly resurfacing.

Angela Haskell, PharmD, BCPS, BCIDP, infectious diseases clinical pharmacy specialist at The Christ Hospital in Cincinnati, provides an expert look into the upcoming respiratory virus season.

Tom Kraus, JD, of ASHP, and Shawn Gremminger, MPP, of the National Alliance of Healthcare Purchaser Coalitions, face off on the 340B Drug Pricing Program.

In part 2, Blank argues that the language on a medication’s label deserves the same regulatory scrutiny given to the drugs themselves and how they affect patients.

Researchers explore prenatal alcohol use among expectant mothers in the US spanning 2011 to 2024.

Study findings underscore health care’s gradual push into the technologically driven future of health care, leaving in-store destinations behind.

Managing diabetes has shifted from reactive monitoring to a proactive, technology-driven standard of care that emphasizes real-time data and personalized treatment.

Sharon Blank, CEO of RxTran and Language Scientific, discusses language hurdles in the safe delivery of medications for patients and pharmacists alike.

Researchers design, implement, and evaluate the use of social determinants of health screening and referral services within Medicaid payer programs.

Pharmacists were asked about their perceived knowledge and attitudes toward patients with Down syndrome.

In the first of a 2-day hearing on peptide therapy access, the FDA votes in favor of approving 4 of the products discussed, with the potential for more on Friday.

Experts collaborate on the best approaches for boosting immunization rates in populations across school campuses and shared living facilities.

As the pharmacist’s role continues to expand throughout health care, they are now being challenged to step in as opioid stewards in a rapidly evolving pain management landscape.

Through pharmacists’ statewide billing capabilities, researchers explore how educational support impacts community pharmacies’ medical billing.

Through the lens of pharmacist satisfaction, researchers assess the implementation and real-world use of medication alert systems.

In part 2, Richard Dion, PharmD, addresses some of the persistent challenges among hospital pharmacies and their pain management models, offering some expert solutions to move forward.